May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
The uveitogenic potential of retinal S–antigen in horses
Author Affiliations & Notes
  • C.A. Deeg
    Inst of Animal Physiology,
    University of Munich, Munich, Germany
  • B. Amann
    Inst of Animal Physiology,
    University of Munich, Munich, Germany
  • S. Reese
    Inst of Veterinary Anatomy,
    University of Munich, Munich, Germany
  • H. Gerhards
    Dept for Equine Surgery,
    University of Munich, Munich, Germany
  • G. Wildner
    Section of Immunobiology, Dept of Ophthalmology,
    University of Munich, Munich, Germany
  • B. Kaspers
    Inst of Animal Physiology,
    University of Munich, Munich, Germany
  • Footnotes
    Commercial Relationships  C.A. Deeg, None; B. Amann, None; S. Reese, None; H. Gerhards, None; G. Wildner, None; B. Kaspers, None.
  • Footnotes
    Support  SFB 571 and DFG/DE 719/1–5
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 568. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C.A. Deeg, B. Amann, S. Reese, H. Gerhards, G. Wildner, B. Kaspers; The uveitogenic potential of retinal S–antigen in horses . Invest. Ophthalmol. Vis. Sci. 2004;45(13):568.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To investigate the uveitogenic potential of retinal S–antigen (S–Ag) in horses. Methods: Horses were immunized subcutaneously with S–Ag or BSA as control antigen, emulsified in complete Freund's adjuvant. Simultaneously, B. pertussis was given intravenously. Antigen specific T and B cell responses were analysed in a 3 day interval. Disease development was judged clinically and histopathologically. Two identical booster immunizations were given every four weeks in order to test induction of recurrences. Results: T and B cell responses specific for S–Ag were observed in all immunized horses but were absent in control animals. However, only one of 5 animals developed uveitis. Reimmunization with S–Ag did not lead to a uveitic relapse in this horse. All other horses of the S–Ag and BSA–treated group did neither develop any signs of uveitis, nor had inflammatory infiltrates of the inner eye. Conclusions: Here we show that, in contrast to IRBP, S–Ag is a weak autoantigen in horses. Even though S–Ag immunization leads to the activation of autoreactive T and B–cells, infiltration of the inner eye and induction of uveitis is controlled in the majority of horses.

Keywords: uveitis–clinical/animal model • autoimmune disease 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×